HOME >> BIOLOGY >> NEWS
Researchers Discover How Ulcer Bug Becomes Antibiotic-Resistant

St. Louis, April 13 -- Scientists in Halifax, Nova Scotia, and St. Louis, Mo., have discovered why the bacterium Helicobacter pylori, which causes peptic ulcer disease, is sensitive to metronidazole, a critical component of the leading H. pylori therapy. They also have determined how the bacterium becomes resistant to this drug. H. pylori infects more than half the world's people and is a major early risk factor for stomach cancer.

The researchers' findings also raise concern about a possible link between the drug and stomach cancer in people infected with H. pylori. "The real danger lurks when a person takes metronidazole without the complete complement of drugs that eradicate this bacterium," says Paul S. Hoffman, Ph.D., professor of microbiology and immunology and medicine at Dalhousie University Medical School in Halifax. "When metronidazole is taken alone, it can be activated by one of the bacterium's enzymes to produce hydroxylamine, a mutagen and cancer-causing chemical."

The collaborators describe their findings in the April 14 issue of Molecular Microbiology. Hoffman's graduate student, Avery Goodman, is lead author of the paper.

Metronidazole -- a generic drug sold as Flagyl, MetroGel and Protostat -- is prescribed for dental abscesses, certain vaginal infections and conditions where anaerobic bacteria or protozoan parasites are suspected. It also is the key component in combination therapies for peptic ulcer disease. But between 10 percent and 30 percent of H. pylori strains in the United States and Western Europe are metronidazole-resistant. In developing countries, the proportion may be as high as 80 percent. This resistance is the most common reason for treatment failure, renewal of infection and recurrence of peptic ulcers and other stomach lesions.

The researchers discovered that metronidazole resistance results from mutation in a gene called rdxA. This gene codes for one of the nitro
'"/>

Contact: Linda Sage
sage@medicine.WUSTL.edu
314-432-8566
Washington University School of Medicine
15-Apr-1998


Page: 1 2 3 4

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... Lithuania , March 21, 2017   ... and object recognition technologies, today announced the release ... kit (SDK), which provides improved facial recognition using ... cameras on a single computer. The new version ... to improve accuracy, and it utilizes a Graphing ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  Continue ... ... to match face pictures against each other or against large databases. The recognition ... ... software for biometric Face Matching on the market. The speed is at 100 ...
Breaking Biology News(10 mins):
(Date:5/22/2017)... ... May 22, 2017 , ... Cancer diagnostics ... in booth B2 at the Association for Pathology Informatics Annual Summit ... addition to demonstrating its Cancer Diagnostic Cockpit and Consultation Portal, Inspirata will present ...
(Date:5/19/2017)... PA (PRWEB) , ... May 19, 2017 , ... ... its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and ... New Jersey and Delaware, are encouraged to submit proposals. QED, now in its ...
(Date:5/18/2017)... ... May 17, 2017 , ... NDA Partners Chairman Carl Peck, MD , ... Advantar Laboratories and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined ... Cardinal Health, he was former Chief Operating Officer at Anaborex, Senior VP and General ...
(Date:5/18/2017)... (PRWEB) , ... May 17, 2017 , ... ... and equipment for varying industries, including food and dairy, munitions, and pharmaceutical/biotech, recently ... operator safety and ease of use. The improvement in technology comes on the ...
Breaking Biology Technology:
Cached News: